Trading Of Pharmaceuticals Companies in Malaysia

The Malaysian government has been proactive in recent years in attracting foreign direct investment (FDI) in the pharmaceutical sector. As a result, the country has attracted a number of multinational pharmaceutical companies to set up operations in Malaysia.

The Malaysian government offers a number of incentives to foreign investors in the pharmaceutical sector, including tax exemptions and duty-free import of raw materials. These incentives have helped to make Malaysia an attractive destination for pharmaceutical companies looking to expand their operations in Southeast Asia.

The Malaysian government is also supportive of the development of the domestic pharmaceutical industry. The government has set up a number of initiatives to promote the research and development of new drugs and therapies.

The Malaysian pharmaceutical market is expected to grow at a compound annual growth rate (CAGR) of 9.5% from 2016 to 2021. The growth of the pharmaceutical market is driven by the growing demand for medicines, the expanding healthcare infrastructure, and the government’s supportive policies.

The top five pharmaceutical companies in Malaysia are GlaxoSmithKline, Pfizer, Novartis, Roche, and AstraZeneca. These companies have a strong presence in the country and are engaged in the manufacturing, marketing, and distribution of a wide range of pharmaceutical products